In line with a previous report by our group,22 we also observed a high frequency of CD39+ CD8+ tumor-infiltrating lymphocytes (TILs) in CRC (tet-MR1-negative T cells; Figure 3A). This evidence concerns the gene ENTPD1 and neoplasm.